Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PROLENSA safely and effectively. See full prescribing information for PROLENSA. PROLENSA ®(bromfenac ophthalmic solution) 0.07%, for topical ophthalmic use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
PROLENSA ®is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
- generic_name
- bromfenac sodium
- product_names
- Bromfenac Sodium
- ndc
- 24208-602, 24208-602-01, 24208-602-03, 24208-602-06, 24208-602-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en